Last updated: 2026/04/01
- Home
- About
- Healthcare Professionals
- Patients
- News
- Company News
- Zylox-Tonbridge Announces Annual Financial Results for 2023, Demonstrating Robust Growth and Improved Profitability
- Zylox-Tonbridge Hosts Investor Open Day, Showcasing Innovation Pipeline and Global Growth Strategy
- Zylox-Tonbridge and Avinger Forge Strategic Partnership to Expand Disruptive OCT Solutions for Peripheral Vascular Interventions
- Zylox-Tonbridge’s ZYLOX Venous Stent System Receives NMPA Marketing Approval
- The 2023 Investor Open Day of Zylox-Tonbridge was successfully held
- Zylox-Tonbridge Reveals 2023 Interim Financial Results: Revenue Surges 50.7% YOY to 230 Million Yuan, Gross Profit Climbs to 171 Million Yuan
- Zylox-Tonbridge to be Added to MSCI China All Shares Small Cap Index
- Approval Granted for Full Circulation of Zylox-Tonbridge H shares, Significantly Raising its Circulation Market Capitalization
- Zylox-Tonbridge Announces Financial Results for 2022: Revenue Increases by 87.8% YOY to RMB 334 million and Gross Profit Reaches RMB 253 million
- Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions
- Zylox-Tonbridge's Strategic Investment in Wire Sciences Boosts the Development of Innovative Vascular Intervention Surgical Robots
- ZYLOX-TONBRIDGE Postdoctoral Workstation was Officially Inaugurated to Help Cultivate High-level Talents in the Medical Device Industry
- ZYLOX-TONBRIDGE Completed Patient Enrollment for Its Flow Diverter Clinical Trial in Less Than Five Months
- ZYLOX-TONBRIDGE Holds First Investor Day Event to Explore Development Opportunities for Domestic Substitution
- Zylox-Tonbridge successfully holds the national launch meeting for Tonbridge Gekko™ Coil System
- ZYLOX-TONBRIDGE Made Exclusive Technology Collaboration with SKY ROAD to Enrich its Product Portfolio
- Zylox-Tonbridge: Neurovascular Embolization Coils obtains NMPA approval for marketing in advance, demonstrating the strong R&D capabilities
- Zylox-Tonbridge: Talent recruitment to gather pace upon approval of H-share incentive trust scheme by General Shareholders' Meeting
- Zylox-Tonbridge Sets up Beijing Office and Shanghai R&D Center to Attract High-Quality Talents and Strive for Rapid Development
- Zylox-Tonbridge: Tonbridge Gycline™ Microcatheter Obtains Marketing Authorization from NMPA Ahead of Schedule
- Zylox-Tonbridge completes patient enrollment in the PEVENSEY study for Zynlastic™ peripheral venous stent system
- Zylox-Tonbridge Brings a New Option for Overseas Patients with Acute Ischemic Stroke
- 2021 ZYLOX-TONBRIDGE INDUSTRIAL PARK OPENING CEREMONY
- TonBridge Medical was selected as a technology-based SMEs in Guangdong
- SWEDEPAD Interim Analysis Shows No Mortality Difference Found for Paclitaxel-Coated Devices.
- TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020
- TonBridge Medical obtained the certificate of intellectual property management system certification
- Zylox Medical's Staff ran the 2020 Hangzhou Dream Town Half Marathon
- TonBridge Medical won two Bronze Award of
- Zylox Medical's ZENFluxion™ and ZENFLEX Pro™ Received CE Certificate
- TonBridge Medical was promoted as an industrial enterprise above designated size
- Zylox-Tonbridge Assisted Turkish Hospitals in Post-earthquake Recovery
- TonBridge Medical held a launch meeting for the Clot Retriever Device and the Intracranial Support Catheters
- The Intracranial Support Catheter obtained medical device registration certificate
- The Clot Retriever Device obtained medical device registration certificate
- ThromBite™ gained CE certificate
- Zylox-TonBridge Medical was selected as one of the top 50 most valuable investment companies in China in 2019
- TonBridge Medical won the runner-up of the 2018 China Innovation and Entrepreneurship Competition in Biomedical Industry Finals (medical device group champion)
- Zylox Medical wins Second prize in the 6th China Innovation and Entrepreneurship Competition
- Zylox Medical Receives CE Mark for ZENFlex Peripheral Stent System
- Zylox-Tonbridge: Approval for Commercialization of Multiple Products Enabled 544% Year-on-year Revenue Growth for the Company in 2021
- Zylox-Tonbridge: PTA Balloon Catheter — Large Diameter Obtains Marketing Approval from NMPA
- Tonbridge Webinar：BGC in Transradial Neurointerventions
- Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22
- Zylox-Tonbridge Receives Approval to Launch ZYLOX Octoplus™ IVC Filter from NMPA
- Zylox-Tonbridge’s ZENFlow Tiger™ LD PTA Dilatation Catheter Receives ANVISA Marketing Approval
- Zylox-Tonbridge was Added to the FTSE Global Equity Index Series
- Zylox-Tonbridge Completed Patient Enrollment for ZENFLEX® Peripheral Stent System Clinical Trial in the EU
- Zylox-Tonbridge’s ZYLOX® Phoenix Peripheral Detachable Fibered Coil Embolization System Receives NMPA Marketing Approval
- Zylox-Tonbridge Receives Marketing Approvals for Multiple Products in the UAE
- Zylox-Tonbridge Reports Strong Interim Financial Results for 2024, Achieving Significant Growth and Profitability
- Zylox-Tonbridge 2024 Investor Open Day Successfully Held in Hangzhou
- ZYLOX Unicorn™ Vascular Closure Device Receives Regulatory Approval in Indonesia
- 2024 Environmental, Social and Governance Report
- Zylox-Tonbridge Issues Positive Profit Alert, Expects Over RMB 115 Million in 1H 2025 Net Profit
- Seeing is Believing | First Case of Pantheris Completed in Boao, Hainan
- Zylox-Tonbridge to Acquire Equity Interest in A European Medical Device Company to Accelerate Expansion in the Global MedTech Market
- Zylox-Tonbridge Announces Positive Profit Alert: Net Profit Expected to Increase by Approximately 140% Year-on-Year in FY2025, with Revenue Exceeding RMB 1.05 Billion
- Zylox-Tonbridge Reports 2025 Annual Results with Revenue Exceeding RMB 1.06 Billion and Net Profit Up 143.7% Year-over-Year
- Industry News
- Events
- Information For Patients
- Join Us
- Investor Relations
- Announcement & Circulars
- Dissemination of Corporate Communications
- Notice Of Board Meeting
- Announcement Regarding The H Share Full Circulation Listing Approval Granted By The Stock Exchange
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
- Voluntary Announcement - Unaudited Operating Statistics For The Year Ended December 31, 2021
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 December 2021
- Voluntary Announcement - The Strategic Investment In Wire Sciences
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 November 2021
- Voluntary Announcement Completion Of Patient Enrollment For The Flow Diverter Clinical Trial
- Voluntary Announcement Intention Of The Chairman To Increase Shareholding In The Company
- Inside Information Announcement Approval By The Csrc Of The Company's Application For The Full Circulation Of H Shares
- Voluntary Announcement - Collaboration Agreement With Sky Road
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 October 2021
- An Announcement Has Just Been Published By The Issuer In The Chinese Section Of This Website, A Corresponding Version Of Which May Or May Not Be Published In This Section
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 30 September 2021
- Notification Letter and Request Form to Non-registered Shareholders
- Interim Report 2021
- Voluntary Announcement National Medical Products Administration Granted Marketing Approval For Neurovascular Embolization Coils In China
- Articles Of Association
- Poll Results Of The 2021 Third Extraordinary General Meeting
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 August 2021
- Form Of Proxy For 2021 Third Extraordinary General Meeting
- Notice Of 2021 Third Extraordinary General Meeting
- (1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Amendments To The Articles Of Association;
- (1) Proposed Adoption Of The 2021 H Share Award And Trust Scheme; (2) Proposed Authorization To The Board And/or The Delegatee To Handle Matters Pertaining To The 2021 H Share Award And Trust Scheme; (3) Proposed Change Of Registered Address; (4) Proposed
- Interim Results Announcement For The Six Months Ended June 30, 2021
- Notice Of Board Meeting
- Monthly Return Of Equity Issuer On Movements In Securities For The Month Ended 31 July 2021
- Voluntary Announcement Unaudited Operating Statistics For The Period From January 1, 2021 To June 30, 2021
- Next Day Disclosure Return
- Full Exercise Of The Over-allotment Option, Stabilizing Actions And End Of Stabilization Period
- Voluntary Announcement Completion Of Patient Enrollment For The Clinical Trial Of Zynlastic Peripheral Venous Stent System
- List Of Directors And Their Roles And Functions
- Terms Of Reference For The Nomination Committee
- Terms Of Reference For The Remuneration Committee
- Terms Of Reference Of The Audit Committee
- Articles Of Association
- Announcement Of Offer Price And Allotment Results
- Green Application Form
- Global Offering
- Global Offering
- PHIP (1st Submission)
- PHIP (1st Submission)1
- Application Proof (1st Submission)
- Application Proof (1st Submission)
- Voluntary Announcement Unaudited Operating Statistics For The Year Ended December 31, 2021
- Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities
- Announcement Regarding Completion Of The H Share Full Circulation
- Announcement Of Annual Results For The Year Ended December 31, 2021
- Next Day Disclosure Return - July
- Post Hearing Information Pack of Zylox-Tonbridge Medical Technology Co., Ltd.
- Application Proof of Zylox-Tonbridge Medical Technology Co., Ltd.
- Annual Report 2021
- CIRCULAR OF 2021 ANNUAL GENERAL MEETING, 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- NOTICE OF 2021 ANNUAL GENERAL MEETING
- NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
- NOTICE OF 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- FORM OF PROXY FOR 2021 ANNUAL GENERAL MEETING
- FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES
- FORM OF PROXY FOR 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- VOLUNTARY ANNOUNCEMENT - NATIONAL MEDICAL PRODUCTS ADMINISTRATION GRANTED MARKETING APPROVAL FOR PTA BALLOON CATHETER - LARGE DIAMETER IN CHINA
- VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE 2021 H SHARE AWARD AND TRUST SCHEME
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
- POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING, THE 2022 FIRST CLASS MEETING OF HOLDERS OF H SHARES AND 2022 FIRST CLASS MEETING OF HOLDERS OF DOMESTIC SHARES
- LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
- CHANGE OF ADDRESS OF H SHARE REGISTRAR
- UPDATE ANNOUNCEMENT IN RELATION TO THE AMENDMENTS TO THE ARTICLES OF ASSOCIATION
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
- ARTICLES OF ASSOCIATION
- NOTICE OF BOARD MEETING
- Interim Report 2023
- UPDATE ON QUALIFICATION OF THE JOINT COMPANY SECRETARY
- Prospectus & Financial Report
- Corporate Information
- Financial Calendar & Contact
- Presentation Materials
- Contact Us
